Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2010
Transduction of tumor-specific T cells with CXCR2 chemokine receptor improves migration to tumor and antitumor immune responsesWeiyi Peng, Yang Ye, Brian A Rabinovich, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 17, 2012
Agonistic antibody to CD40 boosts the antitumor activity of adoptively transferred T cells in vivoChengwen Liu, Carol M Lewis, Yanyan Lou, et al.
Research Square|April 25, 2024
Development of a First-in-Class RIPK1 Degrader to Enhance Antitumor ImmunityJin Wang, Dong Lu, Xin Yu, et al.
Science Signaling|September 29, 2016
Bypassing STAT3-mediated inhibition of the transcriptional regulator ID2 improves the antitumor efficacy of dendritic cellsHaiyan S Li, Chengwen Liu, Yichuan Xiao, et al.
Biorxiv : the Preprint Server for Biology|April 9, 2024
Development of a First-in-Class RIPK1 Degrader to Enhance Antitumor ImmunityXin Yu, Dong Lu, Xiaoli Qi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 11, 2011
Antitumor activity mediated by CpG: the route of administration is criticalYanyan Lou, Chengwen Liu, Gregory Lizée, et al.
Cancer Immunology, Immunotherapy : CII|September 14, 2019
Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signatureEmily Hinchcliff, Cherie Paquette, Jason Roszik, et al.
Nature Communications|December 16, 2024
Development of a RIPK1 degrader to enhance antitumor immunityXin Yu, Dong Lu, Xiaoli Qi, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2025
Soluble Immune Factor Profiles in Blood and CSF Associated with LRRK2 Mutations and Parkinson's DiseaseRoshni Jaffery, Yuhang Zhao, Sarfraz Ahmed, et al.
Pageof 8